Military finally studying menopause in servicewomen and veterans
S. 1320 — Servicewomen and Veterans Menopause Research Act · Filed by Patty Murray (D-WA) · 10 cosponsors · Introduced Apr 8, 2025 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Defense and Department of Veterans Affairs to evaluate existing research on menopause and mid-life women's health among servicewomen and veterans, identify gaps in knowledge and treatment options, assess training resources for military and VA healthcare providers, and submit a report with recommendations and a strategic research plan within 180 days. It does not appropriate funds or mandate new research, but expresses Congress's sense that such research should be conducted.
Why we flagged it
The bill is a straightforward directive to federal health agencies to evaluate and report on menopause research gaps and training needs specific to military and veteran populations, with a non-binding sense of Congress encouraging further research.
What the text implies
- The bill's focus on combat-related exposures (burn pits, PFAS, toxic chemicals) may surface previously undocumented health impacts on servicewomen, potentially creating liability or compensation pressure on DoD.
- Identifying gaps in menopause treatment and provider training could lead to future appropriations requests or mandate expansion of VA/DoD healthcare services.
The full analysis lists 3 implications of this text.
Who it affects
Servicewomen and female veterans gain from improved understanding of menopause-related health issues specific to military service (including combat exposure, burn pit exposure, and PFAS contamination), better provider training, and identification of treatment gaps. The bill creates no new restrictions on citizens' rights or remedies and imposes no costs on the general public.